Federal Regulators Target Healthcare's Biggest Data Gatekeeper as Epic Systems Faces Antitrust Probe

The Federal Trade Commission and multiple state attorneys general have launched an investigation into Epic Systems Corp., the electronic health records behemoth that controls medical data for 57% of U.S. inpatient hospital beds, according to a STAT News report. The early-stage probe focuses on whether the Madison, Wisconsin-based company is wielding its market power to block rival health technology firms—particularly AI-driven startups—from accessing the patient data they need to operate.

The investigation comes as Epic's annual revenue has surged to $5.7 billion in 2024, up from $3.3 billion in 2020, and as approximately 82% of Americans now have at least one medical record stored in Epic's systems. Federal and state investigators are reportedly conducting interviews about two main concerns: restrictive employee non-compete agreements and alleged practices that prevent third-party software vendors from accessing customer data.

The "Epic-First Policy" and Data Access Disputes

At the heart of the investigation are allegations that Epic has implemented what competitors describe as an "Epic-first policy"—requiring hospital customers to abandon preexisting third-party tools and forgo non-Epic solutions if the company believes it has overlapping capability, even when Epic's competing product is still "under development."

A company brochure titled "Products You Can Replace with Epic" reportedly lists 323 products across 21 categories, with 16 of those categories labeled as under development. This aggressive expansion strategy has triggered multiple lawsuits from competitors who claim Epic is using its gatekeeper position to eliminate competition.

CureIS Healthcare filed suit in 2025 alleging that Epic blocked its access to customer data after designating CureIS as a competitor to Epic's Tapestry product. The company claims it lost at least seven customers, including Sutter Health, and a nine-figure acquisition deal as a result. Similarly, Particle Health sued Epic, claiming the vendor cut off customer access to patient records using what Particle characterized as a pretext of inappropriate record access, resulting in the loss of at least 10 customers, though some claims were subsequently dismissed.

Implications for Healthcare AI Innovation

The investigation carries significant implications for the burgeoning health AI sector, where access to comprehensive patient data is essential for developing and deploying clinical decision support tools, population health analytics, and care coordination platforms. If Epic's alleged practices are restricting data access to potential competitors, AI companies may face substantial barriers to entry in a market where a single vendor controls the majority of patient records.

The timing is notable: Epic's longtime AI leader Seth Hain and Sumit Rana—rumored to be heir apparent to founder Judith Faulkner—both departed the company in July 2026, along with several other longtime executives. These departures come as Epic faces mounting legal and regulatory pressure over its competitive practices.

Epic has also faced labor-related lawsuits, including one from Veeva Systems over restrictive non-compete agreements and stock purchase agreements, which was dismissed for lack of standing but is under appeal. Another case brought by Andrea Hull remains pending in California regarding blocked access to Epic's UserWeb platform.

What's at Stake

For healthcare providers, the investigation raises questions about whether Epic's policies limit their ability to adopt best-in-class AI solutions. If hospitals are pressured to abandon third-party tools in favor of Epic's own products—including those still in development—it could delay access to innovative capabilities and reduce competitive pressure on Epic to deliver cutting-edge features.

For patients, restricted interoperability could slow the adoption of AI-powered tools that might improve diagnostics, treatment planning, and care coordination. In a healthcare system increasingly reliant on artificial intelligence, the outcome of this investigation could determine whether innovation flourishes or faces obstacles from a single dominant vendor.

The probe is still in its early stages, and Epic has not publicly commented on the investigation. Founded in 1979 by Judith Faulkner with a $70,000 investment, Epic has grown into healthcare's most powerful technology company—and now faces its most serious regulatory scrutiny to date.

Sources

1. Epic's alleged anti-competitive practices under scrutiny from federal, state investigators — STAT News